Search the GHTC website
January 31, 2024

GHTC responds to US consultation on pandemic accord

GHTC responded to a public request for comment on the pandemic accord negotiations that was released by the US Department of Health and Human Services' Office of Global Affairs. GHTC's comments focused on the need for the accord to feature provisions that incentivize continuous research and development, facilitate equitable access to medical countermeasures, and strengthen regulatory capacity.

January 26, 2024

GHTC contributes to statements delivered at WHO Executive Board meeting on NTDs, TB, and AMR

GHTC contributed to statements delivered by the Global Health Council at the 154th World Health Organization (WHO) Executive Board (EB) meeting on global health R&D agenda items: neglected tropical diseases (NTDs), tuberculosis (TB), and antimicrobial resistance (AMR).

January 11, 2024

GHTC signs letter to US administration stakeholders in support of funding for Gavi, the Vaccine Alliance

GHTC signed onto a letter, compiled by ONE and RESULTS, to the White House Office of Management and Budget and other stakeholders in the Biden Administration, urging full funding, in line with the global health community's request of $340 million, and continued support for Gavi, the Vaccine Alliance in the fiscal year 2025 President's Budget Request.

January 4, 2024

GHTC signs letter urging congressional leaders to avoid funding cuts to vital programs

GHTC signed a letter signed by 850 organizations urging congressional leaders to adopt the Senate's government funding framework as the starting point for a final fiscal year 2024 appropriations deal to avoid the possibility of steep cuts to vital programs funded by non-defense discretionary appropriations that could be enacted in other funding scenarios.